Your browser doesn't support javascript.
loading
Nilotinib combined with multi-agent chemotherapy in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center prospective study with long-term follow-up.
Liu, Bingcheng; Wang, Ying; Zhou, Chunlin; Wei, Hui; Lin, Dong; Li, Wei; Liu, Kaiqi; Zhang, Guangji; Wei, Shuning; Li, Yan; Gong, Benfa; Liu, Yuntao; Gong, Xiaoyuan; Mi, Yingchang; Wang, Jianxiang.
Afiliação
  • Liu B; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China.
  • Wang Y; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China.
  • Zhou C; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China.
  • Wei H; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China.
  • Lin D; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China.
  • Li W; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China.
  • Liu K; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China.
  • Zhang G; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China.
  • Wei S; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China.
  • Li Y; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China.
  • Gong B; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China.
  • Liu Y; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China.
  • Gong X; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China.
  • Mi Y; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China.
  • Wang J; Luekemia Center, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, 300020, China. wangjx@ihcams.ac.cn.
Ann Hematol ; 98(3): 633-645, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30635765
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China